E-Therapeutics stable as it pivots to drug discovery
Drug discovery company e-Therapeutics announced its full year results for the year to 31 January on Wednesday, with cash and deposits of £14.0m at year-end, down from £24.8m.
Drug discovery company e-Therapeutics announced its full year results for the year to 31 January on Wednesday, with cash and deposits of £14.0m at year-end, down from £24.8m.